|
Press Releases |
|
 |
|
Wednesday, July 1, 2020 |
|
Remap-Cap to Partner With Eisai on Innovative Trial to Combat COVID |
The Global Coalition for Adaptive Research (GCAR), in collaboration with UPMC (University of Pittsburgh Medical Center), and Eisai announced today that Eisai will join REMAP-COVID, a substudy of REMAP-CAP (A Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia) that tests multiple interventions for the treatment of patients hospitalized with COVID-19. more info >> |
|
Thursday, June 25, 2020 |
|
Eisai Receives Approval for Parkinson's Disease Treatment Equfina in South Korea |
Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai's subsidiary in South Korea, has received marketing approval of Parkinson's disease treatment Equfina (safinamide mesilate, "safinamide"). more info >> |
|
Wednesday, June 10, 2020 |
|
Eisai to Support Counter-Measures Against the Spread of the Novel Coronavirus Infection in Africa |
Eisai Co., Ltd. announced today that it has committed the equivalent of 1 million USD in aid towards various activities in response to the spread of the novel coronavirus infection in Africa, beginning with the activities described below. more info >> |
|
Thursday, June 4, 2020 |
|
Eisai: Brain Performance (Brain-Health) Self-Check Tool "NouKNOW" to be Used in Beauty Salons |
Eisai Co., Ltd. announced today that the digital tool for self-assessment of brain performance (brain health) "NouKNOWTM", which Eisai has launched in Japan, is to be expanded in the fixed-rate membership beauty salon "Attina", which is operated by Youforio Co., Ltd. more info >> |
|
Tuesday, June 2, 2020 |
|
Eisai Launches New Insomnia Drug Dayvigo (Lemborexant) CIV in the United States as a Treatment Option for Adults With Insomnia |
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has launched its in-house discovered orexin receptor antagonist DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance in the U.S. on June 1, 2020. more info >> |
|
Friday, May 29, 2020 |
|
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody |
AbbVie GK and Eisai Co., Ltd. today announced an approval of partial changes in the marketing approval of HUMIRA (generic name: adalimumab [recombinant], hereafter "HUMIRA"), a fully human anti-TNFalpha monoclonal antibody, for additional dosage and administration, specifically, to add an 80mg every-other-week (Q2W) regimen as a treatment option for patients with hidradenitis suppurativa (HS) after the first 4 weeks of treatment. more info >> |
|
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials |
The two trials, Study 116/KEYNOTE-524 and Study 111/KEYNOTE-146, examined patients with unresectable hepatocellular carcinoma (HCC) with no prior systemic therapy and patients with metastatic clear cell renal cell carcinoma (ccRCC) who progressed following immune checkpoint inhibitor therapy, respectively. more info >> |
|
Monday, May 18, 2020 |
|
Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules |
Eisai Co., Ltd. announced today that it has launched New Selbelle Premium Tablets and New Selbelle Premium Fine Granules (both are category-2 OTC drug, "New Selbelle Premium") on May 18, 2020. more info >> |
|
Thursday, May 14, 2020 |
|
Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting |
Eisai Co., Ltd. announced today that presentations on a series of abstracts regarding its in-house discovered lenvatinib mesylate and eribulin mesylate will be given at the American Society of Clinical Oncology, from May 29 to 31, 2020. more info >> |
|
Monday, April 27, 2020 |
|
Eisai Selected as Most Honored Company and the First Place of the Sector in "The All-Japan Executive Team (Best IR Company Ranking)" by Institutional Investor Magazine |
This selection is based on Eisai's being ranked first place in "Best CEOs" and "Best CFOs", respectively, in the sector. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Euro Manganese Announces Early Appointment of Chairman and Provides Financing Update
Apr 16, 2025 03:40 HKT/SGT
|
|
|
Kincora Copper: Second Major Earn-In Secured with AngloGold Ashanti
Apr 16, 2025 03:23 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Launch of Field X Fashion, Issue 2, Brand's Award-Winning Global, Digital Magazine Celebrating Sport and Fashion
Apr 15, 2025 22:07 HKT/SGT
|
|
|
Ausnutria Delivers Resilient Dual Growth in Revenue and Profit in 2024
Apr 15, 2025 22:06 HKT/SGT
|
|
|
Bahrain Launches Informational Website and Hotline for the Golden Residency to Attract Global Professionals and Investors
Apr 15, 2025 22:06 HKT/SGT
|
|
|
TransNusa Becomes First Indonesian Airline to Launch Scheduled Bali - Guangzhou Route
Apr 15, 2025 22:05 HKT/SGT
|
|
|
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 22:04 HKT/SGT
|
|
|
Standard Chartered GBA Business Confidence Survey shows calm before tariff storm in Q1
Apr 15, 2025 18:57 HKT/SGT
|
|
|
Kincora Copper: Investor Briefing Webinar - Sixth Asset Level Agreement
Apr 15, 2025 18:09 HKT/SGT
|
|
|
CTF Life Supports 10 Local Schools with Donations of Dr MAC Classroom Reading Programme and Learning Living Chinese Programme
Apr 15, 2025 17:52 HKT/SGT
|
|
|
Isuzu and Fujitsu sign partnership agreement to commercialize software defined vehicles
Apr 15, 2025 12:29 JST
|
|
|
MHI Awarded a Study on CO2 Capture Modules for FPSOs
Apr 15, 2025 10:46 JST
|
|
|
3rd ASEAN Procurement Innovation Summit & Awards 2025 - The Next Frontier in Procurement Excellence
Apr 14, 2025 23:19 HKT/SGT
|
|
|
Global strategic speakers confirmed to accelerate energy transformation at Japan Energy Summit & Exhibition 2025
Apr 14, 2025 23:00 HKT/SGT
|
|
|
Guangdong Syntrust GK Testing and Certification Tech Service Center Co., Ltd. Announces the First Annual Results after Listing, with a Significant Increase of 33.16% in Revenue
Apr 14, 2025 19:41 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|